RmKK, a tissue kallikrein inhibitor from Rhipicephalus microplus eggs

Patrícia A Abreu1, Tatiane S Soares1, Diego S Buarque1

  • 1Department of Biochemistry, Universidade Federal de São Paulo, São Paulo, SP, Brazil.

Insights

Researchers identified and characterized a novel tissue kallikrein inhibitor (RmKK) from Rhipicephalus microplus tick eggs. This inhibitor may play a crucial role in tick development and disease transmission.

Area of Science:

  • Biochemistry
  • Parasitology
  • Molecular Biology

Background:

  • Rhipicephalus microplus is a significant ectoparasite causing anaplasmosis and babesiosis in cattle.
  • Tissue kallikrein inhibitors are implicated in tick egg development and survival.

Purpose of the Study:

  • To purify and characterize a tissue kallikrein inhibitor from Rhipicephalus microplus eggs (RmKK).
  • To investigate the inhibitory activity of RmKK against serine proteases.
  • To determine the origin and function of RmKK in tick reproduction and development.

Main Methods:

  • Purification of RmKK from Rhipicephalus microplus eggs.
  • Amino terminal determination and dissociation constant (Ki) measurements.
  • cDNA cloning, recombinant protein expression in Pichia pastoris, and purification.
  • Mass spectrometry (MALDI-TOF) for molecular mass determination.

Main Results:

  • RmKK was purified and confirmed as a Kunitz-type inhibitor.
  • Recombinant RmKK exhibited potent inhibition of bovine trypsin (Ki=0.2 nM) and porcine pancreatic kallikrein (PPK) (Ki=300 nM).
  • The transcript for RmKK is produced in the adult female gut, suggesting its role in egg development.

Conclusions:

  • RmKK is a novel and potent inhibitor of serine proteases found in Rhipicephalus microplus eggs.
  • RmKK likely plays a critical role in the development of tick eggs and larvae.
  • This finding offers potential targets for tick control strategies.